glp-1 management platform startups Riding the Wegovy wave: The shifting focus to GLP-1s to tap the $150bn weight loss drug market digital health companies glp-1 management
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] Pridal L, Ingwersen SH, Larsen FS, Holst JJ, Adelhorst K, Kirk O
FDA approves once-weekly Wegovy injection for the treatment of obesity in teens aged 12 years and older
Phone calls go to voicemail, the in-portal chat icon doesnt function, and email replies take at least a business day
The Precision Peptide Genetic Test ($99 add-on) analyzes your GLP1R, GIPR, FTO, and MC4R variants across 150+ genetic insights, helping your provider predict semaglutide response and tolerability
Ketone bodies can actually inhibit approximately 40 percent of basal GLP-1 secretion through the FFAR3 receptor
While there is no direct drug-drug interaction between Wegovy and Wellbutrin, several safety considerations warrant attention when these medications are used together
